Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 4, 2022

50715_rns_2022-07-04_d7e4bf4f-51d1-497d-94a3-42bd927c25d9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

4 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase /Sale Totalnumber ofsharesinvolved Total amountpaid /received Highest (H)prices paid/ received Lowest (L)prices paid/ received
ChinaInternationalCapitalCorporationLimited 30 June2022 Ordinaryshares Disposal of the underlying sharesreceived from the redemption ofpre-existing index-tracking ETFs as aresult of unsolicited client requests Sale 2,000 $78,480.0000 $39.2400 $39.2400
Ordinaryshares Hedging as a result of the creation ofnew index-tracking ETFs where therelevant securities represent lessthan 1% of the class in issue and lessthan 20% of the value of thesecurities in the basket or index Purchase 600 $23,857.0000 $39.7800 $39.7250

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.